In the era of Precision Medicine, the traditional "one-size-fits-all" therapeutic approach is rapidly being superseded by targeted interventions. Shenzhen BioX Medical Co., Ltd. stands at the forefront of this revolution as a premier Custom OEM Companion Diagnostic Tools Supplier. Companion Diagnostics (CDx) have transitioned from being "nice-to-have" laboratory accessories to essential clinical tools that determine the safety and efficacy of high-stakes biological therapies.
The global companion diagnostics market is projected to grow at a CAGR of 12.5% through 2030. This growth is driven by the oncology sector, where molecular testing for biomarkers like EGFR, HER2, and PD-L1 is mandatory before initiating therapy. As a specialized OEM supplier, we recognize that pharmaceutical companies require more than just a test kit; they need a robust, scalable diagnostic platform that can be integrated into clinical trials across diverse geographies.
Our PC-32 Mini Thermal Cycler exemplifies the shift toward Point-of-Care (POC) testing. Future roadmaps focus on integrating ultra-fast PCR cycling (under 15 minutes) with microfluidic cartridges to provide hospital-grade results in clinic settings.
Integration of machine learning algorithms into our Gel Imaging Analysis Systems and Color Doppler Ultrasound allows for automated feature extraction, reducing human error in diagnostic interpretation.
Leveraging IoT, as seen in our Central RO Systems, enables real-time diagnostic monitoring and predictive maintenance, ensuring that clinical lab downtime is virtually eliminated.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
The advantage of partnering with a Shenzhen-based OEM supplier lies in the "Industrial Synergy" of the region. BioX Medical leverages the world's most concentrated electronics and medical component ecosystem to offer:
Our FIPV Diagnosis machines are revolutionizing pet clinics in Europe and Southeast Asia, providing rapid DNA-based pathogen detection for feline infectious peritonitis, a previously difficult-to-diagnose condition.
The KSTK Modular Industrial Oxygen Generator supports localized ozone generation for water treatment and medical sterilization in regions with limited gas infrastructure.
The Lightweight CT PT on-Site Diagnostic Platform offers mobility for field hospitals and disaster relief zones where permanent diagnostic infrastructure is unavailable.
The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
Navigating the regulatory landscape (FDA, IVDR, NMPA) is the greatest challenge for diagnostic tool providers. BioX Medical provides full-spectrum support:
We provide comprehensive technical files and validation data to support your local registration requirements. Our facility adheres to strict ISO 13485 standards, ensuring that every OEM product is "Registration Ready."
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions.
A: A CDx tool is specifically designed to provide information essential for the safe and effective use of a corresponding therapeutic product. Our OEM service covers the engineering of the hardware, the optimization of the molecular assay, and the software UI localization.
A: We offer transparent IP frameworks where the client retains the rights to their specific biomarkers and proprietary assay configurations, while BioX provides the specialized instrument platform IP.
A: Yes, our software engineering team can localize interfaces into multiple languages and integrate with local Laboratory Information Systems (LIS) or Hospital Information Systems (HIS).
A: For modifications to existing platforms (like our PCR systems), lead time is typically 3-6 months. Full ground-up custom developments take 12-18 months depending on regulatory complexity.
Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine.
BioX Medical
